Biocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, en...

Cipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib...

Shares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...

India's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...

Dasatinib Tablet is indicated for the treatment of newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) i...

The drug substance patent on Dasatinib was owned by Bristol-Myers-Squibb and had expired on 12 April 12, 2020. The current monthly therapy ...

CDRI in Lucknow, scientists recently found that certain leprosy drugs might help treat myeloma, a type of blood cancer.

Japanese firm Otsuka Pharmaceuticals, Myers-Squibb, Novartis are deferring launch of medicines critical for treatment of serious non-commun...

CML is a type of blood cancer characterized by uncontrolled growth of white blood corpuscles (WBCs) in the bone marrow leading to imbalance...

The ministry has sought details from the Health Ministry, which had approached the DIPP for issuance of compulsory licences.

Today’s Supreme Court judgment on the Glivec case means that innovator companies like Novartis will see little protection for intellectual ...

Gleevec, the pill that offered an easy way to target a difficult type of leukemia, may cause serious heart damage, researchers cautioned.